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Anxiety in women with lymphedema 
following treatment for breast cancer
Abstract
Introduction: The aim of the present study was to evaluate anxiety in women with lymphedema following treatment 
for breast cancer. 
Material and methods: A cross-sectional study was conducted involving 32 consecutive patients with lymphedema 
stemming from breast cancer treatment. Women with lymphedema due to other causes were excluded. Anxiety was 
evaluated using the Beck Anxiety Inventory. Descriptive statistics were used for the analysis of events. 
Results: Among the 32 patients evaluated, 10 (31.25%) had a minimal level of anxiety, 10 (31.25%) had mild anxiety, 
seven (21.85%) has moderate anxiety and had mild to moderate depression and five (15.62%) had severe anxiety. 
Conclusions: In this study anxiety occurs in different degrees in women with lymphedema following treatment for 
breast cancer of moderate to severe anxiety.
Psychiatry 2019; 16, 4: 175–177
Key words: lymphedema, anxiety, breast cancer, treatment
Introduction
Breast cancer is the most frequent form of cancer 
among women and among the three most prevalent 
forms of all types of cancer (11.6%) [1]. Analyzing 
mortality trends due to breast cancer in 36 European 
countries and the European Union between 1970 and 
2014, a reduction is seen from 17.9/100,000 women 
in 2002 to 15.2/100,000 in 2015, with a predicted 
rate of 13.4/100,000 by 2020. The drop was greater 
among younger women (20 to 49 years, 22% reduction 
between 2002 and 2012) and the largest drop found 
in the United Kingdom [2]. In Brazil, 59,700 new cases 
of breast cancer are expected in the current two-year 
period (2018–2019), with an estimated risk of 56.33 out 
of every 100 thousand women. In 2016 a mortality for 
breast cancer rate was 15,4 deaths in Brazil [3]. Breast 
cancer is the second major cause of death among women 
in the United States [4]. 
Although divergences of opinion have been found in 
recent years regarding the diagnosis and treatment of this 
disease, it is important to detect and treat breast cancer 
as early as possible. Detection is performed with imaging 
techniques and biopsy. The treatment options for women 
with breast cancer are surgery, radiotherapy, chemothe-
rapy and molecular treatments. Breast reconstruction is 
an elective procedure and the Brazilian public healthcare 
system offers this option to all women who desire it [5].
One of the complications that may arise after treatment 
is lymphedema, which is the incapacity of the lymphatic 
system to mobilize protein and macromolecules from the 
cellular interstitium [6]. This condition exerts an effect on 
functional status. The accompanying edema, loss of joint 
mobility, increase in weight and bodily asymmetry, along 
with the disfigurement stemming from a mastectomy, 
can lead to depression, anxiety and fear regarding what 
the future may hold, thereby directly interfering with 
overall quality of life [7].
Like depression, anxiety is a mental illness, but to define 
anxiety in the point of view of psychiatry seems quite 
divergent by the fact that the concept is used under the 
control of different and associated events [8]. From the 
psychological standpoint, the main manifestation of anxiety 
is described as a vague, nonspecific sensation of some 
type of threat to one’s wellbeing [9]. Anxiety and fear are 
recognized as being pathological when disproportional to 
the stimulus or qualitatively divergent from what is seen as 
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normal for a particular age group, with negative impacts 
on quality of life, emotional comfort and the performance 
of activities of daily living [10]. An individual in a state of 
anxiety may focus on a single aspect that exerts an influence 
on how fears and concerns are manifested, which often 
become excessive, painful and pathological. Anxiety most 
often appears to be related to future prospects. 
The aim of the present study was to evaluate anxiety in 
women with lymphedema stemming from treatment 
for breast cancer. 
Material and methods
Participants and setting
This study was developed at the Godoy Clinic in São José 
do Rio Preto, Brazil, involving 32 women 45 to 76 years 
of age (mean: 61.5 years) with lymphedema stemming 
from breast cancer treatment.
Study design
A cross-sectional study was conducted with 32 conse-
cutively recruited women.
Inclusion criteria
Women with a clinical diagnosis of lymphedema stem-
ming from breast cancer treatment were included in the 
present study. Lymphedema was defined as a volume 
≥200 mL greater in one limb compared to the contra-
lateral limb at the initial evaluation prior to inclusion in 
the rehabilitation group. 
Exclusion criteria
Women with lymphedema who had not undergone 
breast cancer treatment and lymphedema due to other 
causes were excluded from the study.
Development of study 
All participants were submitted to an evaluation using 
the Beck Anxiety Inventory [11], which is a self-report 
measure with 21 multiple-choice items used to deter-
mine perceptions of anxiety. The items address different 
symptoms and each item has four scored response 
options: 0  = not at all, 1 = mildly, 2 = moderately 
and 3 = severely. The reliability of the scale depends 
exclusively on the patient’s honesty when completing 
the questionnaire. The total ranges from 0 to 63 points 
and is interpreted as follows: 0 to 7 points = minimal 
anxiety; 8 to 15 points = mild anxiety; 16 to 25 points = 
moderate anxiety; and 26 to 63 points = severe anxiety.
Statistical analysis
Descriptive statistics were used for the analysis of events. 
Ethical considerations
This study received approval from the Human Research 
Ethics Committee of the São Jose do Rio Preto School 
of Medicine (certificate number: 2.541.206). All partici-
pants signed a statement of informed consent.
Results
Among the 32 patients evaluated, 10 (31.25%) had 
a minimal level of anxiety, 10 (31.25%) had mild anxiety, 
seven (21.85%) has moderate anxiety and had mild to 
moderate depression and five (15.62%) had severe anxiety. 
Discussion 
The present findings show moderate to severe anxiety 
in 37% of women with lymphedema stemming from 
treatment for breast cancer. The literature offers few 
studies on anxiety in these patients, but body image is 
one of the influential factors in this respect. Two bodily 
issues coincide in women having undergone treatment 
for breast cancer — the disfigurement resulting from the 
removal of the breast, which is a symbol of womanhood 
that is associated with pleasure, sensuality, sexuality and 
motherhood [12], and lymphedema, which is a dimorphi-
sm of the arm on the operated side [13]. This process 
causes a change in the life course of these women that 
requires a coping response and adaptation to the new 
situation, which does not always occur. 
Women with lymphedema stemming from treatment for 
breast cancer report a set of negative factors that can oc-
cur simultaneously, such as the fear of the recurrence of 
the tumor, pain, changes in activities of daily living [14], 
changes in family relations and fear with regard to the 
future, all of which can contribute to anxiety. The initial 
diagnosis as well as its association with death and the 
adverse effects of treatment can trigger anxiety, which is 
often not addressed and can consequently continue for 
long periods, compromising emotional, physical, psycho-
logical and social aspects of the patient’s life. Therefore, 
a multidisciplinary team should be involved beginning 
with the early phase of treatment, with interventions to 
ensure that patients maintains their physical activities and 
receive supports with regard to adapting to the changes 
to come and the maintenance of healthy family relations. 
Health professionals should understand the correlation 
between coping and anxiety to be able to develop mea-
sures that can help these patients choose effective coping 
strategies and reduce their level of anxiety. 
Conclusion
In this study anxiety occurs in different degrees in women 
with lymphedema following treatment for breast cancer 
of moderate to severe anxiety. 
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